Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Yan Liang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3002-5431; OpenAlex author ID A5082895932. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
52
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 4 papers · 2020: 1 paper · 2021: 2 papers

Papers 8

  1. USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer. Co-author DOI 10.1101/gad.348787.121↗
  2. Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition. Co-author DOI 10.1158/0008-5472.can-20-3792↗
  3. Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Co-author DOI 10.1038/s41591-020-0947-8↗
  4. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Co-author DOI 10.1038/s41586-019-1062-1↗
  5. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Co-author DOI 10.1038/s41591-019-0368-8↗
  6. YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci.insight.130811↗
  7. Glucose Metabolism in Pancreatic Cancer. Co-author DOI 10.3390/cancers11101460↗
  8. Analyzing S100A6 expression in endoscopic ultrasonography-guided fine-needle aspiration specimens: a promising diagnostic method of pancreatic cancer. Co-author DOI 10.1097/mcg.0b013e3182601752↗

Closest collaborators

The 25 strongest of 52 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haoqiang Ying · 6 shared papers, 2019–2021 · strength 0.51
  2. Wantong Yao · 5 shared papers, 2019–2021 · strength 0.48
  3. Alec C. Kimmelman · 3 shared papers, 2019–2021 · strength 0.25
  4. Timothy Paul Heffernan · 3 shared papers, 2019–2021 · strength 0.24
  5. Jun Yao · 3 shared papers, 2019–2021 · strength 0.24
  6. Jason B. Fleming · 3 shared papers, 2019–2021 · strength 0.24
  7. Ya’an Kang · 2 shared papers, 2019–2021 · strength 0.18
  8. Bo Tu · 2 shared papers, 2019–2021 · strength 0.18
  9. Alessandro Carugo · 2 shared papers, 2019–2021 · strength 0.17
  10. Ronald Anthony Depinho · 2 shared papers, 2019–2021 · strength 0.17
  11. Pingping Hou · 2 shared papers, 2019–2021 · strength 0.17
  12. Bjoern Papke · 2 shared papers, 2019–2020 · strength 0.14
  13. Emanuel F. Petricoin · 2 shared papers, 2019–2020 · strength 0.14
  14. Nina V. Chaika · 2 shared papers, 2019–2020 · strength 0.14
  15. J. Nathaniel Diehl · 2 shared papers, 2019–2020 · strength 0.14
  16. Venugopal Gunda · 2 shared papers, 2019–2020 · strength 0.14
  17. Mariaelena Pierobon · 2 shared papers, 2019–2020 · strength 0.14
  18. Daniel Zeitouni · 2 shared papers, 2019–2020 · strength 0.14
  19. Yingxue Wang · 2 shared papers, 2019–2020 · strength 0.14
  20. Kirsten L. Bryant · 2 shared papers, 2019–2020 · strength 0.14
  21. Adrienne D. Cox · 2 shared papers, 2019–2020 · strength 0.14
  22. Erik S. Knudsen · 2 shared papers, 2019–2020 · strength 0.14
  23. Pankaj Kumar Singh · 2 shared papers, 2019–2020 · strength 0.14
  24. Jennifer E. Klomp · 2 shared papers, 2019–2020 · strength 0.14
  25. Agnieszka Katarzyna Witkiewicz · 2 shared papers, 2019–2020 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.